Published in J Clin Oncol on January 01, 1992
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer (2006) 0.94
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach. Br J Cancer (1995) 0.89
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma. Bone Marrow Transplant (2009) 0.84
Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer. World J Surg (2001) 0.83
Clinical research methodology I: introduction to randomized trials. J Am Coll Surg (2008) 0.82
Assessment of effectiveness of percutaneous adhesiolysis in managing chronic low back pain secondary to lumbar central spinal canal stenosis. Int J Med Sci (2012) 0.81
Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support. Br J Cancer (1996) 0.80
Hyperthermia for locally advanced breast cancer. Int J Hyperthermia (2010) 0.80
Pharmacoeconomic evaluation of lenograstim. Conclusions and future directions. Pharmacoeconomics (1994) 0.78
High-dose chemotherapy of metastatic breast cancer: the end of the beginning? Br J Cancer (1997) 0.78
Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience. Br J Cancer (2003) 0.78
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group. Br J Cancer (1996) 0.77
Stem-cell transplantation for the treatment of advanced solid tumors. Springer Semin Immunopathol (2004) 0.77
High-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result. Cancer Res Treat (2005) 0.75
Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer. Br J Cancer (1997) 0.75
Recent advances in the systemic therapy of breast cancer. Ochsner J (2000) 0.75
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer. Biol Blood Marrow Transplant (2012) 0.75
Breast cancer: evaluating trial results. J Clin Oncol (1992) 0.75
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer. Br J Cancer (1995) 0.75
Retracted A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors. Indian J Urol (2007) 0.75
Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy. Br J Cancer (2002) 0.75
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study. Br J Cancer (1998) 0.75
Benzothiadiazole induces disease resistance in Arabidopsis by activation of the systemic acquired resistance signal transduction pathway. Plant J (1996) 4.10
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. Med Phys (1998) 3.00
Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Proc Natl Acad Sci U S A (1980) 2.72
Young people, alcohol, and designer drinks: quantitative and qualitative study. BMJ (1997) 2.64
Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc Natl Acad Sci U S A (1994) 2.53
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet (1999) 2.42
Missed opportunities for early diagnosis of cancer of the cervix. Am J Public Health (1980) 2.41
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37
Improved survival for patients with acute myelogenous leukemia. J Clin Oncol (1995) 2.30
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med (1988) 2.23
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol (2005) 2.23
Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion (1997) 2.17
The significance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol (1983) 2.08
Overexpression of metallothionein confers resistance to anticancer drugs. Science (1988) 2.03
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VI. Characterization of the DNA from five nondefective hybrid viruses. J Virol (1973) 2.01
Assessment of established cases of chronic simple glaucoma. Br J Ophthalmol (1970) 1.94
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res (1981) 1.91
Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide. Ann Intern Med (2000) 1.90
Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol (1996) 1.85
Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis Rheum (1996) 1.83
Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant (2001) 1.82
Genome size and complexity in Azotobacter chroococcum. J Gen Microbiol (1984) 1.79
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol (2000) 1.77
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis (1982) 1.72
Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears. Acta Cytol (1985) 1.70
The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis (1978) 1.65
Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A (1993) 1.63
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun (2001) 1.60
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (1996) 1.58
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol (1988) 1.56
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol (1989) 1.55
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. Int J Radiat Oncol Biol Phys (1996) 1.55
Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys (1999) 1.53
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
Pain mechanisms in osteoarthritis of the knee: effect of intraarticular anesthetic. J Rheumatol (1996) 1.51
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol (2001) 1.48
Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet (1988) 1.43
Retracted A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys (1989) 1.43
Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci U S A (1995) 1.42
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Ann Intern Med (2000) 1.42
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med (1972) 1.40
The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Endotheliotropic elephant herpes virus (EEHV) infection. The first PCR-confirmed fatal case in Asia. Vet Q (2006) 1.38
Comment: the past and future of national comprehensive tobacco control legislation. Am J Public Health (1998) 1.28
Pitfalls of patient education. Limited success of a program for back pain in primary care. Spine (Phila Pa 1976) (1996) 1.25
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol (1999) 1.25
The cytochrome P-450 active site. Regiospecificity of prosthetic heme alkylation by olefins and acetylenes. J Biol Chem (1983) 1.24
The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol (1980) 1.24
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23
Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol (1998) 1.23
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci (1994) 1.22
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res (1996) 1.21
Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg (1992) 1.17
Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis. J Infect Dis (1982) 1.17
Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2006) 1.17
Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance. Cancer Res (1999) 1.16
Uniocular open-angle glaucoma. Am J Ophthalmol (1968) 1.15
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. Clin Cancer Res (2001) 1.15
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol (1992) 1.15
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res (1986) 1.15
Point-source outbreak of coccidioidomycosis in construction workers. Epidemiol Infect (2009) 1.14
The use of static perimetry in the early detection of glaucoma. Can J Ophthalmol (1967) 1.13
Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother (1984) 1.12
Part II. Educating for diversity: a decade of experience (1989-1999) J Womens Health Gend Based Med (1999) 1.12
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest New Drugs (1997) 1.12
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood (1998) 1.12
Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res (1981) 1.12
Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun (2002) 1.11
Quality of life and dissociation in anxiety disorder patients with histories of trauma or PTSD. Am J Psychiatry (1993) 1.10
Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res (1988) 1.10
Studies of the pH gradient and thickness of frog gastric mucus gel. Gastroenterology (1983) 1.10
High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol (1990) 1.09
Vascular smooth muscle cell kinetics: a new assay for studying patterns of cellular proliferation in vivo. Science (1979) 1.09
Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus. Proc Natl Acad Sci U S A (1984) 1.09
Looking for human papillomavirus type 16 by PCR. Lancet (1990) 1.09
Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis (1997) 1.09
Part I. "Behind every problem lies an opportunity": meeting the challenge of diversity in medical schools. J Womens Health Gend Based Med (1999) 1.08
Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis. N Engl J Med (1979) 1.07
Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse: implications for Qa function and class I evolution. EMBO J (1989) 1.07
Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol (1996) 1.07
The influence of sample takers on the cellular composition of cervical smears. Acta Cytol (1986) 1.05
Experimental nondestructive electrical stimulation of the brain and spinal cord. J Neurosurg (1970) 1.05
Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. N Engl J Med (1987) 1.05
Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion (1997) 1.04
Curli loci of Shigella spp. Infect Immun (2000) 1.04
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol (1989) 1.04